— Know what they know.
Not Investment Advice

364970.KS Holdings

MiraeAsset TIGER Bio TOP10 ETF
1W: +4.0% 1M: -7.8% 3M: -4.7% YTD: -23.4% 1Y: -12.4% 3Y: +18.9% 5Y: -34.5%
₩6,840.00 ($5.09)
-125.00 (-1.79%)
 
Weekly Expected Move ±3.5%
₩6363 ₩6602 ₩6840 ₩7078 ₩7317
ETF KSC · AUM ₩271.5B
ETF-Level Metrics
AUM$271.5B
Holdings—
Top 10 Wt—%
Beta0.31
% Profitable—%
Coverage98%
Portfolio Valuation
P/E32.6
P/B4.5
P/S12.0
EV/EBITDA25.5
P/FCF51.8
PEG0.48
Profitability & Returns
Gross Margin58.1%
Net Margin36.2%
ROE13.4%
ROA9.7%
ROIC10.4%
Div Yield0.19%
Leverage & Liquidity
Debt/Equity0.20
Debt/Assets0.14
Net Debt/EBITDA0.3x
Interest Cov29.0x
Current Ratio1.56
Quick Ratio0.93
Growth (YoY)
Revenue+23.2%
Net Income+108.7%
EPS+82.3%
FCF+73.6%
EBITDA+23.4%
Rev CAGR 3Y+25.6%
Quality Scores
Piotroski F5.9
Altman Z27.53
IS Quality74.6
IS Overall66.3
IS Value42.7
Median P/E26.4

Sector Breakdown

2 sectors
Sector # Holdings Total Weight % Avg P/E
Healthcare 10 99.9% 46.6
Other 1 0.1% —

Smart Money Overlap

0 holdings with signals
No holdings with active convergence signals
Showing 11 of 11 holdings · Page 1 of 1
# Name Ticker Weight % ▼ Mkt Value Shares P/E Mkt Cap Sector
1 Celltrion 068270.KS 25.38% $61.9B 348,311 26.4 $41.9T Healthcare
2 SAMSUNG BIOLOGICS 207940.KS 25.20% $61.4B 44,173 31.6 $62.7T Healthcare
3 Alteogen 196170.KQ 23.73% $57.9B 227,380 82.4 $18.1T Healthcare
4 HLB 028300.KQ 5.85% $14.3B 344,690 -25.0 $5.4T Healthcare
5 Yuhan 000100.KS 4.84% $11.8B 162,207 25.9 $5.5T Healthcare
6 HanmiPharm 128940.KS 3.85% $9.4B 18,828 27.3 $6.4T Healthcare
7 SKBP 326030.KS 3.51% $8.6B 115,138 15.3 $5.9T Healthcare
8 SCD 000250.KQ 2.87% $7.0B 40,552 271.4 $4.8T Healthcare
9 ABL Bio 298380.KQ 2.42% $5.9B 121,655 -35.6 $2.9T Healthcare
10 SAMSUNG EPIS HOLDINGS 0126Z0.KS 2.26% $5.5B 15,931 — $9.1T Healthcare
11 Portfolio Cash Cash — 0.07% $176.2M 176,183,138 — — —

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms